Gao Yaping signed an equity transfer agreement to acquire 5.1% shares of Sichuan Goldstone Asia Pharmaceutical Inc. (SZSE:300434) from Kuai Yixi and Yang Xiaodong for approximately CNY 170 million on July 29, 2021. Under the terms of the transaction, Gao Yaping will acquire an additional 20.5 million shares for CNY 8.23 per share. The payment for the share transfer shall be made within 10 working days after the transfer date of the shares. Post-closing, Gao Yaping will hold 25.11% stake, Kuai Yixi will hold 15.08% stake and Yang Xiaodong will hold 1% stake in Sichuan Goldstone Asia Pharmaceutical Inc. Gao Yaping completed the acquisition of 5.1% shares of Sichuan Goldstone Asia Pharmaceutical Inc. (SZSE:300434) from Kuai Yixi and Yang Xiaodong on September 16, 2021.